Reuters logo
5 months ago
BRIEF-Anavex Life Sciences says presentation of new mechanism of action data related to Anavex compounds targeting sigma-1 receptor at ad/pd(tm) 2017 meeting
April 3, 2017 / 1:40 PM / 5 months ago

BRIEF-Anavex Life Sciences says presentation of new mechanism of action data related to Anavex compounds targeting sigma-1 receptor at ad/pd(tm) 2017 meeting

April 3 (Reuters) - Anavex Life Sciences Corp

* Anavex Life Sciences says presentation of new mechanism of action data related to Anavex compounds targeting sigma-1 receptor at ad/pd(tm) 2017 meeting

* Anavex Life Sciences - during pathological conditions, Anavex 3-71 showed formation of new synapses between neurons without abnormally increasing no of astrocytes

* Anavex Life Sciences - during Anavex 2-73, Anavex 3-71, Anavex 1-41 showed protective effects of mitochondrial enzyme complexes I, IV during pathological conditions Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below